TRAVERSE BIOSCIENCES
Traverse Biosciences is a privately-held bioscience company established in June 2013 to commercialize a proprietary library of new molecular entities invented at Stony Brook University. Our lead candidate, TRB-N0224, is envisioned as the first FDA-approved, once-daily prescription medication for the prevention and control of canine periodontal disease. We are also pursuing complimentary therapeutic indications for TRB-N0224, as well as additional drug candidates in the pipeline with implications... for both human and veterinary medicine. Traverse Biosciences was named to reflect our core mission to successfully navigate the "valley of death" separating early-stage academic technologies from becoming viable commercial products for the benefit of health, society and the economy. Our business model is centered around the achievement of key technical milestones in alignment with a validated market opportunity and a clear exit strategy. With the support of our investors and stakeholders, our goal is to strategically mitigate product development risks and add tangible commercial value to our assets.
TRAVERSE BIOSCIENCES
Social Links:
Industry:
Biotechnology Manufacturing Therapeutics
Founded:
2013-01-01
Address:
Stony Brook, New York, United States
Country:
United States
Website Url:
http://www.traversebiosciences.com
Total Employee:
1+
Status:
Active
Contact:
6316328577
Email Addresses:
[email protected]
Total Funding:
600 K USD
Technology used in webpage:
SPF Google Font API Google Analytics Google Apps For Business PHP Google Analytics Classic OpenResty Network Solutions DNS Network Solutions Constant Contact
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
Excell Partners
Excell Partners investment in Seed Round - Traverse Biosciences
the Long Island Emerging technologies Fund (LIETF)
the Long Island Emerging technologies Fund (LIETF) investment in Debt Financing - Traverse Biosciences
Accelerate Long Island
Accelerate Long Island investment in Debt Financing - Traverse Biosciences
Official Site Inspections
http://www.traversebiosciences.com
- Host name: vux.netsolhost.com
- IP address: 206.188.192.232
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
